Two 17β-hydroxysteroid dehydrogenases (17HSDs) of estradiol biosynthesis:: 17HSD type 1 and type 7

被引:41
|
作者
Peltoketo, H [1 ]
Nokelainen, P
Piao, YS
Vihko, R
Vihko, P
机构
[1] Bioctr Oulu, FIN-90220 Oulu, Finland
[2] Oulu Univ, WHO, Collaborating Ctr Res Reprod Hlth, FIN-90220 Oulu, Finland
[3] Univ Helsinki, Dept Biosci, Div Biochem, FIN-00014 Helsinki, Finland
关键词
D O I
10.1016/S0960-0760(99)00064-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two 17 beta-hydroxysteroid dehydrogenases (17HSDs), type 1 and type 7, are enzymes of estradiol biosynthesis, in addition to which rodent type 1 enzymes are also able to catalyze androgens. Both of the 17HSDs are abundantly expressed in ovaries, the type 1 enzyme in granulosa cells and type 7 in luteinized cells. The expression of 17HSD7, which has also been described as a prolactin receptor-associated protein (PRAP), is particularly up-regulated in corpus luteum during the second half of rodent pregnancy. A moderate or slight signal for mouse 17HSD7/PRAP mRNA has also been demonstrated in samples of placenta and mammary gland, for example. Human, but not rodent, 17HSD1 is expressed in placenta, breast epithelium and endometrium in addition to ovaries. A cell-specific enhancer, silencer and promoter in the hHSD17B1 gene participate in the regulation of type 1 enzyme expression. The enhancer consists of several subunits, including a retinoic acid response element, the silencer has a binding motif for GATA factors, and the proximal promoter contains adjacent and competing AP-2 and Sp binding sites. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:431 / 439
页数:9
相关论文
共 50 条
  • [1] Proliferative responses to altered 17β-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors
    Jansson, A.
    Gunnarsson, C.
    Stal, O.
    ENDOCRINE-RELATED CANCER, 2006, 13 (03) : 875 - 884
  • [2] Expression of the estradiol-synthesizing 17β-hydroxysteroid dehydrogenases type 1 and type 7 in the nonhuman primate Callithrix jacchus
    Schwabe, I
    Husen, B
    Einspanier, A
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 171 (1-2) : 187 - 192
  • [3] 17β-Hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family;: nomenclature and main characteristics of the 17HSD/KSR enzymes
    Peltoketo, H
    Luu-The, V
    Simard, J
    Adamski, J
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1999, 23 (01) : 1 - 11
  • [4] Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)
    Spadaro, Alessandro
    Negri, Matthias
    Marchais-Oberwinkler, Sandrine
    Bey, Emmanuel
    Frotscher, Martin
    PLOS ONE, 2012, 7 (01):
  • [5] Current knowledge of the multifunctional 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1)
    He, Wanhong
    Gauri, Misra
    Li, Tang
    Wang, Ruixuan
    Lin, Sheng-Xiang
    GENE, 2016, 588 (01) : 54 - 61
  • [6] Retinoic acids promote the action of aromatase and 17β-hydroxysteroid dehydrogenase type 1 on the biosynthesis of 17β-estradiol in placental cells
    Zhu, SJ
    Li, Y
    Li, H
    Wang, YL
    Xiao, ZJ
    Vihko, P
    Piao, YS
    JOURNAL OF ENDOCRINOLOGY, 2002, 172 (01) : 31 - 43
  • [7] The role of the heterocycle in bis(hydroxyphenyl)triazoles for inhibition of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) type 1 and type 2
    Al-Soud, Yaseen A.
    Bey, Emmanuel
    Oster, Alexander
    Marchais-Oberwinkler, Sandrine
    Werth, Ruth
    Kruchten, Patricia
    Frotscher, Martin
    Hartmann, Rolf W.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) : 212 - 215
  • [8] INHIBITORS OF 17-β-HYDROXYSTEROID DEHYDROGENASE TYPE 3 (17-β-HSD 3)
    Olusanjo, M. S.
    Ahmed, S.
    DRUGS OF THE FUTURE, 2009, 34 (07) : 555 - 563
  • [9] Inhibition of Type 1 17β-Hydroxysteroid Dehydrogenase Impairs the Synthesis of 17β-Estradiol in Endometriosis Lesions
    Delvoux, Bert
    D'Hooghe, Thomas
    Kyama, Cleophas
    Koskimies, Pasi
    Hermans, Rob J. J.
    Dunselman, Gerard A.
    Romano, Andrea
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (01): : 276 - 284
  • [10] Overexpression of 17β-Hydroxysteroid Dehydrogenase Type 1 Increases the Exposure of Endometrial Cancer to 17β-Estradiol
    Cornel, Karlijn M. C.
    Kruitwagen, Roy F. P. M.
    Delvoux, Bert
    Visconti, Laura
    Van de Vijver, Koen K.
    Day, Joanna M.
    Van Gorp, Toon
    Hermans, Rob J. J.
    Dunselman, Gerard A.
    Romano, Andrea
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (04): : E591 - E601